Learn about Candidiasis of Skin (C), also known as Candidal Intertrigo, Candidal Paronychia, or Yeast Infection of Skin. This resource provides information for healthcare professionals on diagnosis, treatment, and clinical documentation of cutaneous candidiasis. Find details relevant to medical coding and ICD-10 codes for accurate billing and healthcare records related to skin yeast infections. Explore best practices for managing and documenting Candidiasis cases in various clinical settings.
Also known as
Candidiasis of skin and nails
Fungal skin infection caused by Candida species.
Mucocutaneous candidiasis
Candida infection affecting skin, mucous membranes.
Cellulitis and abscess of finger and toe
Bacterial skin infection, may be secondary to candidiasis.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the candidiasis specified as intertrigo?
When to use each related code
| Description |
|---|
| Yeast skin infection. |
| Yeast infection of the nails. |
| Yeast infection of mouth/throat. |
Coding candidiasis without specifying the affected skin site (e.g., intertrigo, paronychia) can lead to claim rejections and inaccurate data.
Lack of proper clinical documentation supporting the candidiasis diagnosis may trigger audits and compliance issues.
Failing to capture associated conditions like diabetes, which can increase candidiasis risk, impacts severity and reimbursement.
Q: What are the key clinical features differentiating candidiasis of skin (intertrigo, paronychia) from other dermatological conditions like psoriasis or eczema?
A: Candidiasis of skin, encompassing intertrigo and paronychia, presents distinct clinical features that help differentiate it from conditions like psoriasis or eczema. In intertrigo, you'll typically observe beefy-red erythema with satellite pustules and papules in intertriginous areas like skin folds. Paronychia presents as painful swelling and erythema around the nail fold, often with purulent discharge. Unlike the well-demarcated plaques of psoriasis or the dry, lichenified lesions seen in chronic eczema, candidiasis often exhibits maceration and scaling at the borders, with a propensity for moist, warm environments. Microscopic examination with KOH preparation revealing pseudohyphae and budding yeast cells confirms the diagnosis. Explore how different diagnostic tests can aid in accurately distinguishing between these conditions.
Q: How do I choose the most appropriate antifungal treatment strategy for different presentations of cutaneous candidiasis (e.g., mild intertrigo vs. severe paronychia)?
A: Choosing the right antifungal treatment for cutaneous candidiasis depends on the severity and location of the infection. For mild intertrigo, topical antifungal creams like nystatin or clotrimazole are often sufficient. However, for severe paronychia with significant inflammation or involvement of the nail matrix, systemic antifungals like fluconazole may be necessary. In cases of recurrent or resistant infections, consider identifying and addressing predisposing factors such as diabetes, immunosuppression, or prolonged antibiotic use. Culture and sensitivity testing can guide therapy in these situations. Learn more about the latest guidelines for managing complicated cutaneous candidiasis.
Patient presents with clinical manifestations consistent with cutaneous candidiasis (ICD-10-CM B37). Symptoms include erythematous, pruritic rash with satellite lesions located in the [specify location, e.g., intertriginous folds of the groin, axillae, inframammary area; perianal region; nail folds]. Differential diagnosis includes intertrigo, contact dermatitis, psoriasis, and tinea cruris. KOH preparation of skin scrapings reveals pseudohyphae and budding yeast cells, confirming the diagnosis of candidiasis. Risk factors assessed and discussed with the patient include obesity, diabetes mellitus, antibiotic use, immunosuppression, and warm, moist environments. Patient education provided regarding proper hygiene, keeping the affected area dry, and avoiding occlusive clothing. Treatment plan includes topical antifungal therapy with [specify medication, e.g., clotrimazole, miconazole, ketoconazole] cream applied to affected area twice daily for [duration]. Patient advised to follow up if symptoms do not improve within [timeframe] or worsen. Candidal intertrigo, candidal paronychia, and yeast infection of skin were considered as alternate diagnostic terms. Plan to monitor for treatment response and adjust therapy as needed.